Advances in diagnosis and therapy of inflammatory bowel diseases

Česká verzia

Authors: Michal Konečný; Jiří Ehrmann
Authors place of work: II. interní klinika gastroenterologická a hepatologická LF UP a FN Olomouc, přednosta doc. MUDr. Vlastimil Procházka, Ph. D.
Published in the journal: Vnitř Lék 2014; 60(7-8): 625-629
Category: 100th Birthday - prof. Z. Mařatka

Summary

The inflammatory bowel diseases have been an interesting topic not only for gastroenterologists, but also for other medical professionals, since the beginning of the last century, when this group of inflammatory autoimmune diseases was revealed. Logically, the doyen of Czech gastroenterology, Professor MUDr. Zdeněk Mařatka, DrSc., who dedicated a substantial part of his life to research into inflammatory bowel disease, particularly ulcerative colitis, was no exception. The current century is characterized by a very rapid development of scientific research and almost immediate introduction of scientific knowledge into clinical practice. In the area of inflammatory bowel diseases, the biggest advances have been made in diagnosis and therapy. The examination of the small bowel and large bowel by magnetic resonance belongs at the very pinnacle in the non-invasive diagnosis of the lower part of the gastrointestinal tract. The administration of biological therapy to patients with the most severe forms of inflammatory bowel diseases should be considered a breakthrough since the introduction of corticosteroids into the therapy of inflammatory bowel diseases in the 1950s.

Key words:
biological treatment – Crohn's disease – inflammatory bowel disease – ulcerative colitis

Zdroje

1. Mařatka Z. Colitis ulcerosa. Graf Unie: Praha 1948.

2. Mařatka Z. Nové poznatky o patogenezi nespecifických střevních zánětů. Mechanismy tkáňového poškození. Česk Gastroent Výž 1990; 44: 248–256.

3. Crohn BB, Ginzburg L, Openheimer GD. Regional ileitis; a pathological and clinical entity. JAMA 1932; 99: 1323–1329.

4. Havelka J, Kociánová J, Mařatka Z et al. Klinický obraz a diagnostika regionální enteritidy (Crohnovy choroby). Statistický rozbor 303 případů. Česk Gastroent Výž 1993; 47(1): 3–9.

5. Mařatka Z. Incidence of colorectal cancer in proctocolitis. A retrospectice study of 959 cases over 40 years. GUT 1985; 26(1): 43–49.

6. Benýšek L, Kojecký Z. Komplikationen der Colitis ulcerosa in den Jahren 1952–1959 und 1960–1969. Wien Med Wochenschr 1970; 120(16): 272–274.

7. Benýšek L, Kojecký Z. Morbus Crohn v endoskopickém obraze. Česk Gastroent Výž 1976; 30: 271–272.

8. Benýšek L, Guttnerová J. Systémové projevy a přidružené choroby u nemocných s idiopatickou kolitidou a Crohnovou chorobou. Česk Gastroent Výž 1979; 33: 448.

9. Kojecký Z, Krč I, Benýšek L et al. Some immunological aspects of inflammatory bowel disease. Ann Gastroenterol Hepatol 1978; 14: 515–518.

10. Dave-Verma H, Moore S, Singh A. Computed tomographic enterography and enteroclysis: pekls and pitfalls. Curr Probl Diagn Radiol 2008; 37(6): 279–287.

11. Loftus EV. Using CT and MR. Enterografy to Diagnose and Monitor IBD. Gastroenterol Hepatol (NY) 2010; 6(12): 754–756.

12. Bartušek D, Vavříková M, Válek V. Využití ultrazvuku v diagnostice onemocnění střev. Čes a Slov Gastroenterol a Hepatol 2010; 64(4): 18–24.

13. Carter D, Eliakim R Current role of endoskopy in inflammatory bowel disease diagnosis and management. Curr Opin Gastroenterol 2014; 30(4): 370–377.

14. Tachecí I et al. Kapslová endoskopie. Nucleus HK: Hradec Králové 2008. ISBN 978–80–87009–45–1.

15. Svartz N. Salazopyrin, a new sulfanilamide preparation. Acta Med Scand 1942; 110: 557–598.

16. Ishaq S, Green JR Tolerability of aminosalicylates in inflammatory bowel disease. BioDrugs 2001; 15(5): 339–349.

17. Truelove SC, Witts L. Cortisone in ulcerative colitis. Final report on therapeutic trial. BMJ 1955; 2 (4947): 1041–1048.

18. Zbořil V et al. Imunosupresiva v léčbě idiopatických střevních zánětů. Grada Publishing: Praha 2007: 37–46. ISBN 978–80–247–1563–6.

19. Chey WZ. Infliximab for patients with refractory ulcerative colitis. Inflamm Bowel Dis 2001; 7(Suppl 1): S30-S33.

20. Lukáš M, Ďuricová D, Bortlík M et al. Doporučení pro podávání biologické terapie u idiopatických střevních zánětů. Čes a Slov Gastroenterol a Hepatol 2008; 62(5): 285–291.

21. Lukáš M. Biologická terapie idiopatických střevních zánětů. Remedia 2007; 12(4): 27–35.

22. Sica GS, Biancone L. Surgery for inflammatory bowel dinase in the era of laparoskopy. World J Gastroenterol 2013; 19(16): 2445–2448.